Unibest 优贝德
← Back to patent-cliff list

CAS 75-86-5

2-hydroxy-2-methylpropanenitrile

CodesENZA-005、RALT-001

Application context (from source-drug indications)

激素敏感性前列腺肿瘤恩扎卢胺去势抵抗性前列腺肿瘤恩扎卢胺前列腺癌恩扎卢胺HIV感染拉替拉韦钾硬化性胆管炎拉替拉韦钾HTLV-Ⅰ感染拉替拉韦钾慢性肾功能不全拉替拉韦钾复发-缓解型多发性硬化拉替拉韦钾高甘油三酯血症拉替拉韦钾

Source drugs (routes using this intermediate)

DrugTierExpiry
恩扎卢胺EnzalutamideTier A — Act now2027
拉替拉韦钾Raltegravir PotassiumTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.